Form 4 holding
Director, CHAIRMAN, 10%+ Owner
AngioGenex, Inc.
- Security class
- Common Stock
- Shares / value
- 7,507,827
- Estimated value
- Report date
- 31 Aug 2021
- Price
- Ownership
- Direct
Michael Aronstein - Director, CHAIRMAN, 10%+ Owner at AngioGenex, Inc.
Issuer-level insider activity
- Role
- Director, CHAIRMAN, 10%+ Owner
- Issuer ticker
- AGGX
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Michael Aronstein since 12 Aug 2025
Reported holdings for Michael Aronstein in AngioGenex, Inc.
Form 4 holding
Director, CHAIRMAN, 10%+ Owner
AngioGenex, Inc.
- Security class
- Convertible Note
- Shares / value
- 5,240,000
- Estimated value
- Report date
- 02 Nov 2021
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director, CHAIRMAN, 10%+ Owner
AngioGenex, Inc.
- Security class
- Stock Option
- Shares / value
- 5,000,000
- Estimated value
- Report date
- 02 Sep 2021
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Michael Aronstein in AngioGenex, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.